Hadassah

Patient Number Three Saved at Hadassah with World-First Stem Cell Treatment

Thursday, Sep 27 2012

With a world-first placental stem-cell (PLX) treatment, developed by Pluristem, doctors at the Hadassah University Medical Center have saved the life of a third patient suffering from bone marrow disease.

"Following three successful treatments, which were conducted for the first time in the world at the Hadassah Medical Center,” relates Prof. Reuven Or, Director of Hadassah’s Bone Marrow Transplantation and Cancer Immunology Department, “we can say that PLX cells from the placenta saved the life of patients suffering from bone marrow failure. We are very encouraged by the results and hope that future clinical trials will show the effectiveness of the PLX cells. I believe that the PLX treatment holds huge hope for patients who suffer from different conditions of bone marrow failure and, once approved, will be available for every patient who needs it.”

This most recent patient, a 45-year-old man who has acute myeloid leukemia, a form of blood cancer, had undergone chemotherapy and an unrelated bone marrow transplant, but still suffered from a life-threatening shortage of white blood cells. After receiving two intramuscular injections of the placental stem cells, one week apart, his clinical condition and overall well being improved significantly enough for him to be released from the hospital.

In addition to helping the three patients, Pluristem Chief Executive Officer Zami Aberman notes, the data suggests that the PLX cells may be helpful in rescuing both bone marrow transplant failures that were allogeneic (genetically different) as well as autologous (from the patient’s own cells).

 


Read more on Hadssah's Stem Cell Treatment

Related Stories

alt_text

Wednesday, Jul 8 2020

Cancer Trailblazers at Hadassah Prioritize a Spirit of Innovation

For many decades, chemotherapy and radiation were the chief therapies to treat cancer. Today, at major medical centers like the Hadassah Medical Organization, cancer specialists...

READ MORE ›
alt_text

Monday, Jul 6 2020

The Altruism of Donating an Organ During the COVID-19 Pandemic

During the COVID-19 pandemic, altruistic gestures have assumed special meaning as people continue to donate organs to help others live...

READ MORE ›
alt_text

Monday, Jul 6 2020

COVID-19 Pandemic Creates Confusion, Contradictions, and Changeability

“There is simultaneously a profusion of information, but a dearth of answers.” That’s how Barbara Sofer, the Israel director of public relations at Hadassah’s office in Israel...

READ MORE ›
alt_text

Monday, Jul 6 2020

Evolution, Findings, and Outlook—Hadassah Director Reflects on COVID-19

Many people around the world watched with admiration as Israel efficaciously contained COVID-19 at the start of the pandemic with a strict lockdown...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More